Cargando…
Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan
BACKGROUND: The cardiovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, in type 2 diabetic patients after acute myocardial infarction (AMI) has so far remained uncertain. METHODS: We analyzed data from the National Health Insurance Research Database (NHIRD), a...
Autores principales: | Wang, Szu-Heng, Chen, Dong-Yi, Lin, Yu-Sheng, Mao, Chun-Tai, Tsai, Ming-Lung, Hsieh, Ming-Jer, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Chen, Tien-Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482692/ https://www.ncbi.nlm.nih.gov/pubmed/26115092 http://dx.doi.org/10.1371/journal.pone.0131122 |
Ejemplares similares
-
Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study
por: Chen, Dong-Yi, et al.
Publicado: (2015) -
Short- and Long-Term Major Cardiovascular Adverse Events in Carotid Artery Interventions: A Nationwide Population-Based Cohort Study in Taiwan
por: Tsai, Ming-Lung, et al.
Publicado: (2015) -
Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization
por: Mao, Chun-Tai, et al.
Publicado: (2016) -
Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study
por: Liang, Chung-Yu, et al.
Publicado: (2018) -
Outcomes and Characteristics of Patients Undergoing Percutaneous Angioplasty Followed by Below-Knee or Above-Knee Amputation for Peripheral Artery Disease
por: Mao, Chun-Tai, et al.
Publicado: (2014)